Probiotics as a Potential Immunomodulating Pharmabiotics in Allergic Diseases: Current Status and Future Prospects.
10.4168/aair.2018.10.6.575
- Author:
Garima SHARMA
1
;
Sin Hyeog IM
Author Information
1. Academy of Immunology and Microbiology (AIM), Institute for Basic Science (IBS), Pohang, Korea. iimsh@postech.ac.kr
- Publication Type:Review
- Keywords:
Asthma;
atopic dermatitis;
food hypersensitivity;
pharmabiotics;
probiotics
- MeSH:
Asthma;
Dermatitis, Atopic;
Developed Countries;
Dysbiosis;
Food Habits;
Food Hypersensitivity;
Gastrointestinal Microbiome;
Glare;
Hand;
Hypersensitivity;
Prevalence;
Probiotics*
- From:Allergy, Asthma & Immunology Research
2018;10(6):575-590
- CountryRepublic of Korea
- Language:English
-
Abstract:
The prevalence of allergic disorders has dramatically increased over the past decade, particularly in developed countries. Apart from gastrointestinal disorders, neoplasia, genital and dermatological diseases etc., dysregulation of gut microbiota (dysbiosis) has also been found to be associated with increased risk of allergies. Probiotics are increasingly being employed to correct dysbiosis and, in turn, to modulate allergic diseases. However, several factors like strain variations and effector metabolites or component of them in a bacterial species can affect the efficacy of those as probiotics. On the other hand, host variations like geographical locations, food habits etc. could also affect the expected results from probiotic usage. Thus, there is a glaring deficiency in our approach to establish probiotics as an irrefutable treatment avenue for suitable disorders. In this review, we explicate on the reported probiotics and their effects on certain allergic diseases like atopic dermatitis, food allergy and asthma to establish their utility. We propose possible measures like elucidation of effector molecules and functional mechanisms of probiotics towards establishing probiotics for therapeutic use. Certain probiotics studies have led to very alarming outcomes which could have been precluded, had effective guidelines been in place. Thus, we also propose ways to secure the safety of probiotics. Overall, our efforts tend to propose necessary discovery and quality assurance guidelines for developing probiotics as potential immunomodulatory ‘Pharmabiotics.’
